BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/14/2020 10:35:45 AM | Browse: 1252 | Download: 2058
 |
Received |
|
2020-02-03 20:58 |
|
Peer-Review Started |
|
2020-02-03 20:58 |
|
First Decision by Editorial Office Director |
|
2020-02-25 20:13 |
|
Return for Revision |
|
2020-02-25 20:13 |
|
Revised |
|
2020-04-14 21:42 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-04-23 07:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-04-25 14:21 |
|
Articles in Press |
|
2020-04-25 14:21 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-05-13 00:05 |
|
Publish the Manuscript Online |
|
2020-05-14 10:35 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Peter H Cashin, Lana Ghanipour, Malin Enblad and David L Morris |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Peter H Cashin, MD, PhD, Director, Director, Surgeon, Department of Surgical Sciences, Uppsala University, Akademiska sjukhuset, Uppsala 75185, Sweden. peter.cashin@surgsci.uu.se |
| Key Words |
Colorectal cancer; Peritoneal metastases; Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Oxaliplatin; Neutropenia |
| Core Tip |
We investigated neutropenia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) treatment of colorectal cancer with peritoneal metastases. The frequency of neutropenia was 13%; however, it was much more common in the oxaliplatin + irinotecan HIPEC treatment than in the single oxaliplatin HIPEC treatment. Neutropenia did not increase the risk of Clavien-Dindo morbidity. Furthermore, it was found to be an independent prognostic factor for disease-free survival. In conclusion, we found that neutropenia doesn’t appear to be a toxicity limiting factor as it does not increase the postoperative morbidity, but rather a positive prognostic factor that may predict a better outcome. |
| Publish Date |
2020-05-14 10:35 |
| Citation |
Cashin PH, Ghanipour L, Enblad M, Morris DL. Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study. World J Gastrointest Oncol 2020; 12(5): 549-558 |
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i5/549.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i5.549 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
